Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics

被引:0
|
作者
Giuseppe Blasi
Pierluigi Selvaggi
Leonardo Fazio
Linda Antonella Antonucci
Paolo Taurisano
Rita Masellis
Raffaella Romano
Marina Mancini
Fengyu Zhang
Grazia Caforio
Teresa Popolizio
Jose Apud
Daniel R Weinberger
Alessandro Bertolino
机构
[1] Group of Psychiatric Neuroscience,Department of Basic Medical Sciences
[2] Neuroscience and Sense Organs,Department of Education Science
[3] University of Bari ‘Aldo Moro’,undefined
[4] IRCCS ‘Casa Sollievo della Sofferenza’,undefined
[5] Psychology,undefined
[6] Communication Science,undefined
[7] Aldo Moro University,undefined
[8] Lieber Institute for Brain Development,undefined
[9] Johns Hopkins Medical Campus,undefined
[10] National Institutes of Health,undefined
[11] National Institute of Mental Health,undefined
[12] Clinical Brain Disorders Branch,undefined
[13] pRED,undefined
[14] NORD DTA,undefined
[15] F. Hoffman-La Roche Ltd.,undefined
来源
Neuropsychopharmacology | 2015年 / 40卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dopamine D2 and serotonin 5-HT2A receptors contribute to modulate prefrontal cortical physiology and response to treatment with antipsychotics in schizophrenia. Similarly, functional variation in the genes encoding these receptors is also associated with these phenotypes. In particular, the DRD2 rs1076560 T allele predicts a lower ratio of expression of D2 short/long isoforms, suboptimal working memory processing, and better response to antipsychotic treatment compared with the G allele. Furthermore, the HTR2A T allele is associated with lower 5-HT2A expression, impaired working memory processing, and poorer response to antipsychotics compared with the C allele. Here, we investigated in healthy subjects whether these functional polymorphisms have a combined effect on prefrontal cortical physiology and related cognitive behavior linked to schizophrenia as well as on response to treatment with second-generation antipsychotics in patients with schizophrenia. In a total sample of 620 healthy subjects, we found that subjects with the rs1076560 T and rs6314 T alleles have greater fMRI prefrontal activity during working memory. Similar results were obtained within the attentional domain. Also, the concomitant presence of the rs1076560 T/rs6314 T alleles also predicted lower behavioral accuracy during working memory. Moreover, we found that rs1076560 T carrier/rs6314 CC individuals had better responses to antipsychotic treatment in two independent samples of patients with schizophrenia (n=63 and n=54, respectively), consistent with the previously reported separate effects of these genotypes. These results indicate that DRD2 and HTR2A genetic variants together modulate physiological prefrontal efficiency during working memory and also modulate the response to antipsychotics. Therefore, these results suggest that further exploration is needed to better understand the clinical consequences of these genotype–phenotype relationships.
引用
收藏
页码:1600 / 1608
页数:8
相关论文
共 50 条
  • [41] "Selective" serotonin 5-HT2A receptor antagonists
    Casey, Austen B.
    Cui, Meng
    Booth, Raymond G.
    Canal, Clinton E.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2022, 200
  • [42] Serotonin 5HT2a receptor variation and episodic memory
    不详
    [J]. NEUROSCIENTIST, 2004, 10 (05): : 401 - 401
  • [43] Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex
    Szlachta, Marta
    Kusmider, Maciej
    Pabian, Paulina
    Solich, Joanna
    Kolasa, Magdalena
    Zurawek, Dariusz
    Dziedzicka-Wasylewska, Marta
    Faron-Gorecka, Agata
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [44] PRIMARY STRUCTURE OF THE HUMAN PLATELET SEROTONIN 5-HT2A RECEPTOR - IDENTITY WITH FRONTAL-CORTEX SEROTONIN 5-HT2A RECEPTOR
    COOK, EH
    FLETCHER, KE
    WAINWRIGHT, M
    MARKS, N
    YAN, SY
    LEVENTHAL, BL
    [J]. JOURNAL OF NEUROCHEMISTRY, 1994, 63 (02) : 465 - 469
  • [45] Abaperidone hydrochloride.: Antipsychotic, dopamine D2 antagonist, 5-HT2A antagonist
    Bolós, J
    Príncep, M
    Guglietta, A
    [J]. DRUGS OF THE FUTURE, 2001, 26 (04) : 335 - 341
  • [46] NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia
    Umbricht, D
    Vollenweider, FX
    Schmid, L
    Koller, R
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 53S - 53S
  • [47] GENETIC-VARIATION OF 5-HT2A RECEPTOR AND RESPONSE TO CLOZAPINE
    MASELLIS, M
    PATERSON, AD
    BADRI, F
    LIEBERMAN, JA
    MELTZER, HY
    CAVAZZONI, P
    KENNEDY, JL
    [J]. LANCET, 1995, 346 (8982): : 1108 - 1108
  • [48] GENETIC-VARIATION OF THE 5-HT2A RECEPTOR AND RESPONSE TO CLOZAPINE
    NOTHEN, MM
    RIETSCHEL, M
    ERDMANN, J
    OBERLANDER, H
    MOLLER, HJ
    NABER, D
    PROPPING, P
    [J]. LANCET, 1995, 346 (8979): : 908 - 909
  • [49] Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist
    Ohno, Yukihiro
    Okano, Motoki
    Imaki, Junta
    Tatara, Ayaka
    Okumura, Takahiro
    Shimizu, Saki
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (02) : 175 - 180
  • [50] Computational Pharmacophore Modelling of 5-HT2a and D2 Receptor Inhibitors of Schizophrenia
    Zainab, Rida
    Elahi, Sana
    Kaleem, Afshan
    Hoessli, Daniel C.
    Iqtedar, Mehwish
    Abdullah, Roheena
    Saleem, Faiza
    Khan, Shanza
    Ijaz, Anusha
    Naz, Shagufta
    Shakoori, Abdul R.
    [J]. PAKISTAN JOURNAL OF ZOOLOGY, 2018, 50 (06) : 2331 - 2342